The Global Health Body Issues Alert Over Severe Shortage of Weight-Loss Injections
Under 10% of people who could benefit from weight-loss injections such as Wegovy have access to them, caution the World Health Organization as it publishes its inaugural recommendations on the therapies.
With more than one billion people worldwide now classified as obese, it is calling for broader and more equitable access to this class of drugs.
Based on estimates, more than two billion are projected to be living with obesity by 2030 if no action is taken.
"Our latest guidance acknowledges that excess weight is a chronic disease that can be addressed with thorough and ongoing treatment," stated its chief Tedros Adhanom Ghebreyesus.
High costs, constrained manufacturing, and distribution challenges are major hurdles to broad availability to the jabs that can help people shift considerable body mass, says the body.
Skinny Jab Supply Crisis
Even in the current most favorable scenario, the production of these medications might only reach approximately 100 million people – under 10% of those who need them, according to the health organization.
The advice encourages governments and firms to increase availability, through measures like voluntary licensing.
Exclusive production rights on the active ingredient – the main component of the drug Wegovy – is scheduled to end in multiple countries in 2026.
How Obesity Injections Work
The injections replicate a natural hormone to reduce digestion speed, suppress the appetite and enhance feelings of fullness so individuals consume fewer calories.
People usually see weight reduction in the initial weeks of commencing the once-weekly jabs.
Studies points to patients may regain a significant portion after a year of halting the treatment, when their typical appetite return.
Being above a healthy weight increases your risk for contracting medical conditions, including type 2 diabetes, cardiovascular issues, brain attack, and certain malignancies.
Excess weight concerns people in countries worldwide and was responsible for 3.7 million deaths worldwide in 2024, according to the health agency.